Bristol-Myers Taps Senior-VP Strategy Dolan As President
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb appoints Senior-VP Strategy and Organizational Effectiveness Peter Dolan as president, responsible for the firm's worldwide medicines, beauty care and nutritionals businesses. Dolan, who will report to Chairman and CEO Charles Heimbold, also is elected to the BMS board.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: